Defeat of antipiracy treaty is hailed as victory for generic drugsBMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e4660 (Published 09 July 2012) Cite this as: BMJ 2012;345:e4660
- Peter Moszynski
The European parliament’s refusal to ratify the Anti-Counterfeiting Trade Agreement (ACTA) has been warmly welcomed by health and development agencies, which have said that the treaty posed a serious threat to poor countries’ access to generic drugs.1
This is the first time that the parliament has voted against an international trade agreement that had been approved by the European Commission. After massive lobbying by campaigners, which included a petition signed by over 2.8 million people worldwide, the agreement was defeated by an overwhelming majority, with 478 votes against and only 39 in favour.
Oxfam’s spokeswoman Leïla Bodeux said, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial